BANGKOK, June 15 (TNA) – Chulalongkorn University on Monday started the human trial of its ChulaCov19 vaccine after successfully doing it with monkeys and mice.
Prof Dr Sutiipong Wacharasindhu, dean of the Faculty of Medicine at Chulalongkorn University, said the first phase of human trial for ChulaCov19 began with volunteers under supervision by many parties including experts from the Chula Vaccine Research Center to ensure maximal safety.
Past trial with monkeys and mice showed that the vaccine blocked the coronavirus from reaching blood circulation and highly stimulated immunity.
The first stage of human trial covered 72 volunteers divided into two groups. One group had 36 volunteers aged 18-55 years and the other another 36 aged 65-75 years.
The Chula Vaccine Research Center was about to develop another COVID-19 vaccine to cope with resistance to vaccines. The center planned to test its new vaccine in the fourth quarter of this year. (TNA)